NEW YORK (Reuters Health) – Coronary artery stenting does not reduce long-term rates of myocardial infarction (MI) or mortality in patients with stress-positive stable coronary artery disease, German…
NEW YORK (Reuters Health) – Amlodipine decreases central systolic blood pressure more effectively when combined with valsartan than with atenolol, French researchers reported online April 19th in Hypertension.…
NEW YORK (Reuters Health) – Adding inhaled treprostinil (Tyvaso) to oral bosentan for pulmonary arterial hypertension (PAH) improves exercise capacity and quality of life, according to a report…
NEW YORK (Reuters Health) – In patients with diabetic nephropathy, high doses of B vitamins accelerate kidney dysfunction and increase the rate of myocardial infarction (MI) and strokes,…
NEW YORK (Reuters Health) – Intensive insulin therapy, targeting a blood glucose level of 130 mg/dL, may improve the likelihood of survival for severely burned children, according to…
NEW YORK (Reuters Health) – Reperfusing the myocardium within 5 hours of an infarction makes a real survival difference, research from Denmark shows. The study, conducted in patients…
NEW YORK (Reuters Health) – A study published today provides more evidence that proton pump inhibitors (PPI) interfere with clopidogrel. Recommendations from the Society for Cardiovascular Angiography and…
NEW YORK (Reuters Health) – For patients with acute kidney injury, increasing the intensity of hemodialysis over recommended levels does not reduce mortality or improve renal recovery, according…
NEW YORK (Reuters Health) – Using recombinant tissue plasminogen activator (rtPA) within existing licensing limits is fully justified by available data – but there’s not enough data to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…